5-phenylindoline | 104636-54-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 5-phenylindoline
• 英文别名: 5-phenyl-2,3-dihydroindole；5-phenyl-2,3-dihydro-1H-indole
• CAS: 104636-54-6
• 化学式: C₁₄H₁₃N
• mdl: MFCD06802121
• 分子量: 195.264
• InChiKey: OTLWHHHZQLDXEK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  15
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.142
• 拓扑面积：
  12
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  5-phenylindoline 在 chromium(VI) oxide 、 四丁基碘化铵 、 sodium hydride 、 溶剂黄146 、 2,3-二氯-5,6-二氰基-1,4-苯醌 作用下， 以 四氢呋喃 、 1,4-二氧六环 、 乙醇 、 水 、 丙酮 为溶剂， 反应 61.0h， 生成 1-(2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)-5-phenylindoline-2,3-dione
  参考文献：
  名称：

  Synthesis and antiproliferative activities of diversely substituted glycosyl-isoindigo derivatives

  摘要：

  in the course of structure-activity relationship studies, diversely substituted 1-(beta-(D)-glucopyranosyl)-isoindigo derivatives were prepared from commercially available indolines. Their antiproliferative activities were evaluated toward a panel of human solid cancer cell lines (PC 3, DLD-1, MCF-7, M4Beu, A549, PA 1), a murine cell line (L929) and a human fibroblast primary culture to get an insight into the substitution pattern required for the best biological potencies. (c) 2005 Elsevier SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2005.10.004
• 作为产物：
  描述：

  1-乙酰-5-溴吲哚啉 在 四(三苯基膦)钯 sodium hydroxide 、 sodium carbonate 作用下， 以 甲醇 、 乙醇 、 水 、 甲苯 为溶剂， 反应 40.0h， 生成 5-phenylindoline
  参考文献：
  名称：

  Synthesis and antiproliferative activities of diversely substituted glycosyl-isoindigo derivatives

  摘要：

  in the course of structure-activity relationship studies, diversely substituted 1-(beta-(D)-glucopyranosyl)-isoindigo derivatives were prepared from commercially available indolines. Their antiproliferative activities were evaluated toward a panel of human solid cancer cell lines (PC 3, DLD-1, MCF-7, M4Beu, A549, PA 1), a murine cell line (L929) and a human fibroblast primary culture to get an insight into the substitution pattern required for the best biological potencies. (c) 2005 Elsevier SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2005.10.004

文献信息

• [EN] NOVEL COMPOUNDS<br/>[FR] NOUVEAUX COMPOSÉS
  申请人：MISSION THERAPEUTICS LTD

  公开号：WO2017141036A1

  公开（公告）日：2017-08-24

  The present invention relates to novel compounds of formula (I) and methods for the manufacture of inhibitors of deubiquitylating enzymes (DUBs). In particular, the invention relates to the inhibition of ubiquitin C-terminal hydrolase 30 or ubiquitin specific peptidase 30 (USP30). The invention further relates to the use of DUB inhibitors in the treatment of conditions involving mitochondrial dysfunction and in the treatment of cancer.

  本发明涉及式（I）的新化合物和制造去泛素化酶（DUBs）抑制剂的方法。具体而言，本发明涉及抑制泛素C-末端水解酶30或泛素特异性肽酶30（USP30）。本发明还涉及在治疗涉及线粒体功能障碍和治疗癌症方面使用DUB抑制剂。
• DPP IV inhibitors
  申请人：——

  公开号：US20030130281A1

  公开（公告）日：2003-07-10

  The present invention relates to compounds of formula (I) 1 wherein R 1 , R 2 , and X are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with DPP IV, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance.

  本发明涉及以下式（I）的化合物： 其中R1、R2和X如描述和权利要求中所定义，并且其药学上可接受的盐。这些化合物可用于治疗和/或预防与DPP IV相关的疾病，如糖尿病，特别是非胰岛素依赖型糖尿病和糖耐量受损。
• Copper Nanoparticles from Copper Aluminum Hydrotalcite: An Efficient Catalyst for Acceptor- and Oxidant-Free Dehydrogenation of Amines and Alcohols
  作者：Dandu Damodara、Racha Arundhathi、Pravin R. Likhar

  DOI：10.1002/adsc.201300453

  日期：2014.1.13

  An efficient and simple process for the preparation of stable nanocopper(0) on alumina [Cu(0)/Al2O3] from the inorganic composite precursor copper aluminum hydrotalcite (Cu‐Al HT) by a chemical reduction method is described. Cu(0)/Al2O3 was employed as an efficient catalyst in the acceptor‐ and oxidant‐free dehydrogenation of various amines and alcohols to their corresponding dehydrogenated products

  描述了一种通过化学还原方法从无机复合材料前体铜铝水滑石（Cu-Al HT）制备氧化铝[Cu（0）/ Al 2 O 3 ]上稳定的纳米铜（0）的有效且简单的方法。Cu（0）/ Al 2 O 3用作各种胺和醇类的无受体和无氧化剂脱氢反应为其相应的脱氢产物的有效催化剂，收率非常好。通过研究最多五个循环的胺和醇脱氢中的可回收性和可重复使用性，评估了Cu（0）/ Al 2 O 3的稳定性。
• Novel and Selective 5-HT_2C/2B Receptor Antagonists as Potential Anxiolytic Agents:  Synthesis, Quantitative Structure−Activity Relationships, and Molecular Modeling of Substituted 1-(3-Pyridylcarbamoyl)indolines
  作者：Steven M. Bromidge、Steven Dabbs、David T. Davies、D. Malcolm Duckworth、Ian T. Forbes、Peter Ham、Graham E. Jones、Frank D. King、Damian V. Saunders、Susannah Starr、Kevin M. Thewlis、Paul A. Wyman、Frank E. Blaney、Christopher B. Naylor、Fiona Bailey、Thomas P. Blackburn、Vicky Holland、Guy A. Kennett、Graham J. Riley、Martyn D. Wood

  DOI：10.1021/jm970741j

  日期：1998.5.1

  The synthesis, biological activity, and molecular modeling of a novel series of substituted 1-(3-pyridylcarbamoyl)indolines are reported. These compounds are isosteres of the previously published indole urea 1 (SB-206553) and illustrate the use of aromatic disubstitution as a replacement for fused five-membered rings in the context of 5-HT2C/2B receptor antagonists. By targeting a region of space previously

  报道了一系列新的取代的1-（3-吡啶基氨基甲酰基）二氢吲哚的合成，生物活性和分子模型。这些化合物是先前公开的吲哚脲1（SB-206553）的等排体，并说明了在5-HT2C / 2B受体拮抗剂的背景下使用芳香族脱位取代稠合的五元环。通过靶向先前鉴定为在5-HT2C受体上空间允许但在5-HT2A受体上不允许的空间区域，我们已经鉴定出许多化合物，它们是迄今报道的最有效和选择性最强的5-HT2C / 2B受体拮抗剂。根据其整体生物学特征选择了46（SB-221284）作为新的潜在非镇静抗焦虑药进行进一步评估。
• Model studies on a synthetically facile series of N-substituted phenyl-N′-pyridin-3-yl ureas leading to 1-(3-pyridylcarbamoyl) indolines that are potent and selective 5-HT2C/2B receptor antagonists
  作者：Steven M. Bromidge、Steven Dabbs、David T. Davies、Susannah Davies、D.Malcolm Duckworth、Ian T. Forbes、Angela Gadre、Peter Ham、Graham E. Jones、Frank D. King、Damian V. Saunders、Kevin M. Thewlis、Deepa Vyas、Thomas P. Blackburn、Vicky Holland、Guy A. Kennett、Graham J. Riley、Martyn D. Wood

  DOI：10.1016/s0968-0896(99)00228-x

  日期：1999.12

  antagonists have been prepared by rapid parallel synthesis. These N-substituted phenyl-N'-pyridin-3-yl ureas were found to have a range of 5-HT2C receptor affinities and selectivities over the closely related 5-HT2A receptor. Extrapolation of simple SAR, derived from this set of compounds, to the more active but synthetically more complex 1-(3-pyridylcarbamoyl)indoline series allowed us to target optimal

  已经通过快速平行合成制备了一系列的5-HT 2C拮抗剂模型。发现这些N-取代的苯基-N'-吡啶-3-基脲比密切相关的5-HT2A受体具有一系列的5-HT2C受体亲和力和选择性。从这组化合物中衍生出的简单SAR外推至活性更高但合成上更复杂的1-（3-吡啶基氨基甲酰基）二氢吲哚系列，使我们能够靶向最佳取代模式并鉴定有效和选择性的5-HT（2C / 2B）拮抗剂。